Korea MFDS Revises Regulations for Pharma Clinical Trials

 

Clinical Trials of Pharmaceuticals
Clinical Trials of Pharmaceuticals

The Korea Ministry of Food and Drug Safety (MFDS) has revised regulations regarding the approval of clinical trial plans for pharmaceuticals.

This notification will take effect from January 16, 2024.


- Allow the submission of non-animal or human biology-based test (cell-based assays, microphysiological systems, bioprinting, computer modeling, etc.) data for non-clinical trial data.



👉 Contact GCA

Tel. +82-31-360-8180
Email: forest.lee@gca-kr.com


Comments

Popular posts from this blog

Strengthening core mineral supply chains and fostering the post-use battery industry ecosystem systematically

MSIT, Revises and Enforces Enforcement Decree of Radio Act to Improve Radio Regulations

KC EMC | Changes to KC ID Applicant Codes